Bacteria plays a vital role in causing infectious diseases but a new study has suggested that they may even cause one of the most prevalent diseases, Type 2 diabetes.
University of Iowa Research found that prolonged exposure to a toxin produced by Staphylococcus aureus bacteria caused rabbits to develop the hallmark symptoms of Type 2 diabetes, including insulin resistance, glucose intolerance and systemic inflammation.
Research findings suggest that therapies aimed at eliminating staph bacteria or neutralizing the superantigens might have potential for preventing or treating Type 2 diabetes.
The study shows that superantigens interact with fat cells and the immune system to cause chronic systemic inflammation and this inflammation leads to insulin resistance and other symptoms characteristic of Type 2 diabetes.
Professor Patrick Schlievert said that he thinks that they have a way to intercede here and alter the course of diabetes.
He added that they have been working on a vaccine against the superantigens and they believe that this type of vaccine could prevent the development of Type 2 diabetes.
The researched is published in journal mBio.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
